Core B will provide key facilities and expertise for the mechanistic studies in Projects 1 and 2. Understanding the mechanisms underlying rejection and tolerance of heart and lung transplants in the primate experiments described in Projects 1 and 2 will not only help us achieve tolerance but will help us recognize when it is present or absent. The following methodologies will be utilized: 1. Determine the role of MHC disparities on alloresponses by MHC genotyping of donor and recipient monkeys; 2. Investigate the contributions of direct and indirect T cell alloresponses and autoimmune responses to acute/chronic graft rejection; 3. Monitor the frequency, phenotype, antigen specificity, and functions of donor-specific memory T cells present in blood and lymphoid organs of monkeys tested pre- and post-transplantation; 4. Monitor the frequency, phenotype, antigen specificity, and mechanisms of action of regulatory T cells and expand these cells in vitro for adoptive transfers experiments; 5. Analyze B cell subsets and antibodies as well as their functional properties; 6. Monitor pro- and anti-inflammatory cytokines in sera. The knowledge acquired from these experiments will be used to optimize mixed chimerism protocols designed to achieve tolerance of heart and lungs allografts and to assist in the successful translation of those tolerance protocols to the clinic.

Public Health Relevance

The goal of Core B is to characterize the cells, soluble factors, and immune mechanisms implicated in the induction and maintenance of tolerance (indefinite survival of transplants without immunosuppression) to heart and lung transplants. Understanding the mechanisms by which tolerance is induced and maintained will contribute to the successful application of tolerance protocols to human heart and lung transplant recipients.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Schwartz, Lisa
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
Kean, Leslie S; Turka, Laurence A; Blazar, Bruce R (2017) Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy. Immunol Rev 276:192-212
Tanimine, Naoki; Turka, Laurence A; Priyadharshini, Bhavana (2017) Navigating T Cell Immunometabolism in Transplantation. Transplantation :
Alessandrini, Alessandro; Turka, Laurence A (2017) FOXP3-Positive Regulatory T Cells and Kidney Allograft Tolerance. Am J Kidney Dis 69:667-674
Wang, Zhaohui; Zheng, Qian; Zhang, Huiping et al. (2017) Ontak-like human IL-2 fusion toxin. J Immunol Methods 448:51-58
Zheng, Qian; Wang, Zhaohui; Zhang, Huiping et al. (2017) Diphtheria toxin-based anti-human CD19 immunotoxin for targeting human CD19+ tumors. Mol Oncol 11:584-594
Adam, B A; Smith, R N; Rosales, I A et al. (2017) Chronic Antibody-Mediated Rejection in Nonhuman Primate Renal Allografts: Validation of Human Histological and Molecular Phenotypes. Am J Transplant 17:2841-2850
Zuber, Julien; Sykes, Megan (2017) Mechanisms of Mixed Chimerism-Based Transplant Tolerance. Trends Immunol 38:829-843
Benichou, Gilles; Gonzalez, Bruno; Marino, Jose et al. (2017) Role of Memory T Cells in Allograft Rejection and Tolerance. Front Immunol 8:170
Purroy, Carolina; Fairchild, Robert L; Tanaka, Toshiaki et al. (2017) Erythropoietin Receptor-Mediated Molecular Crosstalk Promotes T Cell Immunoregulation and Transplant Survival. J Am Soc Nephrol 28:2377-2392
Hotta, Kiyohiko; Aoyama, Akihiro; Oura, Tetsu et al. (2016) Induced regulatory T cells in allograft tolerance via transient mixed chimerism. JCI Insight 1:

Showing the most recent 10 out of 288 publications